首页 › 基金 › ADAMS STREET PARTNERS LLC › CRVS
ADAMS STREET PARTNERS LLC 对 CRVS 的持仓历史
CORVUS PHARMACEUTICALS INC · 医疗保健
ADAMS STREET PARTNERS LLC 在 Q3 2026 的 13F 申报中披露持有 CRVS(CORVUS PHARMACEUTICALS INC)3,275,616 股,市值约 US$37.7M,约占其申报组合的 10.99%,在其申报持仓中市值排名第 3 位。 ADAMS STREET PARTNERS LLC 最近 13 个申报季度中有 13 个季度披露了 CRVS 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
ADAMS STREET PARTNERS LLC 对 CRVS 的持仓演变
ADAMS STREET PARTNERS LLC 于 Q3 2023 首次披露 CRVS 持仓:3,275,616 股(约 US$4.8M)。 该持仓在 Q2 2026 达到峰值 3,275,616 股,市值约 US$48.9M。 在 13 次申报中,ADAMS STREET PARTNERS LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 3,275,616 股、市值约 US$37.7M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 3.28M | $4.78M | 新进 |
| Q4 2023 | 3.28M | $5.77M | 持有 |
| Q1 2024 | 3.28M | $5.83M | 持有 |
| Q2 2024 | 3.28M | $5.96M | 持有 |
| Q3 2024 | 3.28M | $17.30M | 持有 |
| Q4 2024 | 3.28M | $17.52M | 持有 |
| Q1 2025 | 3.28M | $10.42M | 持有 |
| Q2 2025 | 3.28M | $13.10M | 持有 |
| Q3 2025 | 3.28M | $24.14M | 持有 |
| Q4 2025 | 3.28M | $25.22M | 持有 |
| Q1 2026 | 3.28M | $47.92M | 持有 |
| Q2 2026 | 3.28M | $48.94M | 持有 |
| Q3 2026 | 3.28M | $37.74M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CRVS 与 13F 数据
CRVS(CORVUS PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 62 只申报持有 CRVS,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$107.0M), PERCEPTIVE ADVISORS LLC (US$39.9M), Vivo Capital, LLC (US$32.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CRVS 的基金
- ORBIMED ADVISORS LLC 7.17M 股 · $107.05M · Q2 2026
- PERCEPTIVE ADVISORS LLC 2.67M 股 · $39.85M · Q2 2026
- Vivo Capital, LLC 2.81M 股 · $32.32M · Q3 2026
- BRAIDWELL LP 2.13M 股 · $31.77M · Q2 2026
- Deep Track Capital, LP 2.49M 股 · $28.71M · Q3 2026
- Foresite Capital Management VI LLC 1.83M 股 · $27.36M · Q2 2026
- Boxer Capital Management, LLC 1.10M 股 · $16.43M · Q2 2026
- Catalio Capital Management, LP 1.08M 股 · $16.15M · Q2 2026
- DCF Advisers, LLC 641.50K 股 · $7.39M · Q3 2026
- Nextech Invest Ltd. 450.00K 股 · $6.72M · Q2 2026
- Blue Owl Capital Holdings LP 358.60K 股 · $4.13M · Q3 2026
- Propel Bio Management, LLC 264.31K 股 · $3.04M · Q3 2026
更多关于 ADAMS STREET PARTNERS LLC
常见问题
How long has ADAMS STREET PARTNERS LLC held CRVS?
ADAMS STREET PARTNERS LLC has disclosed CRVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ADAMS STREET PARTNERS LLC's current position in CRVS?
As of Q3 2026, ADAMS STREET PARTNERS LLC holds 3.28M shares of CRVS (CORVUS PHARMACEUTICALS INC), valued at $37.74M, representing 10.99% of its reported portfolio and ranking #3.
Has ADAMS STREET PARTNERS LLC been buying or selling CRVS?
In the latest 13F filing (Q3 2026), ADAMS STREET PARTNERS LLC held unchanged its position in CRVS. The position peaked in Q2 2026 at 3.28M shares.
Which other funds hold CRVS?
Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, PERCEPTIVE ADVISORS LLC, Vivo Capital, LLC, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.